All companies › PVLA

PVLA · PALVELLA THERAPEUTICS, INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells9
Research cases0
Last filing2026-09-15

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-11 — JENKINS GEORGE M · sold 6,520 @ $150.62 2026-09-11 — JENKINS GEORGE M · sold 4,577 @ $151.72 2026-09-11 — JENKINS GEORGE M · sold 1,274 @ $153.06 2026-09-14 — JENKINS GEORGE M · sold 5,632 @ $151.46 2026-09-14 — JENKINS GEORGE M · sold 6,160 @ $152.12 2026-09-14 — JENKINS GEORGE M · sold 1,560 @ $153.10 2026-09-15 — JENKINS GEORGE M · sold 954 @ $149.38 2026-09-15 — JENKINS GEORGE M · sold 263 @ $150.40 2026-09-15 — JENKINS GEORGE M · sold 560 @ $151.33
2026-09-112026-09-15

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

JENKINS GEORGE M Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $PVLA is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-15', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 954.0, 'price': 149.3779, 'value': 142506.52, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 263.0, 'price': 150.4045, 'value': 39556.38, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 560.0, 'price': 151.3263, 'value': 84742.73, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 5632.0, 'price': 151.4625, 'value': 853036.8, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 6160.0, 'price': 152.1159, 'value': 937033.94, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1560.0, 'price': 153.099, 'value': 238834.44, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 6520.0, 'price': 150.6189, 'value': 982035.23, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 4577.0, 'price': 151.7157, 'value': 694402.76, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'JENKINS GEORGE M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1274.0, 'price': 153.0591, 'value': 194997.29, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for PVLA today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.